The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field
Abstract
Purpose: Ductal carcinoma in situ (DCIS) is the fourth leading cancer for women in the United States. Understanding of the biology and clinical behavior of DCIS is imperfect. This article highlights the current knowledge base and the scientific roadmap needed to advance the field. Methods: This article is based on work done by and consultations obtained from leading experts in the field over a 6-month period that culminated in a full-day symposium designed to systematically review the most pertinent MEDLINE published reports and develop a roadmap to elucidate the molecular steps of carcinogenesis, reduce the extent or prevent the need for therapies, eliminate recurrences, and reduce morbidity. Results: Expression profiling of pure DCIS will help elucidate the molecular characteristics that distinguish high-risk lesions from clinically irrelevant lesions. The development of new methods of extracting RNA from processed tissues may provide opportunities for research. Mammography often underestimates the pathologic extent of DCIS; other imaging methods need to be investigated for detection and monitoring of disease stability or progression. Novel biologic agents are being delivered in neoadjuvant clinical trials, and alternative methods for breast irradiation are being studied. Future trials of treatment versus no treatment for biologically selected cases of DCIS should be developed. Conclusion: There is a critical need for a concerted international effort among patients with DCIS, clinicians, and basic scientists to conduct the research necessary to improve fundamental understanding of the biology and clinical behavior of DCIS and prevent development of invasive breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In situ analyses of genome instability in breast cancer
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., et al. (2004) · Nature Genetics · doi:10.1038/ng1409 · Cited by 361
Cited by
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Volinia, S., Galasso, M., Sana, M. E., Wise, T. F., Palatini, J., Huebner, K., & Croce, C. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200010109 · Cited by 359
Ductal carcinoma in situ: to treat or not to treat, that is the question
on behalf of the PRECISION team, van Seijen, M., Lips, E. H., Thompson, A. M., Nik-Zainal, S., Futreal, A., Hwang, E. S., Verschuur, E., Lane, J., Jonkers, J., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0478-6 · Cited by 320
Calcification in breast lesions: pathologists’ perspective
Tse, G. M., Tan, P.-H., Pang, A. L. M., Tang, A. P. Y., & Cheung, H. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.046201 · Cited by 95
Metadata
- Authors
- Kuerer, H. M., Albarracin, C. T., Yang, W. T., Cardiff, R. D., Brewster, A. M., Symmans, W. F., Hylton, N. M., Middleton, L. P., Krishnamurthy, S., Perkins, G. H., Babiera, G., Edgerton, M. E., Czerniecki, B. J., Arun, B. K., & Hortobagyi, G. N.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-01-10
- Volume
- 27
- Issue
- 2
- Pages
- 279-288
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2144385581
- Cited by
- 228
- References
- 1
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field. https://app.cochat.ai/papers/10.1200/jco.2008.18.3103
- The paper
- Kuerer, H. M., Albarracin, C. T., Yang, W. T., Cardiff, R. D., Brewster, A. M., Symmans, W. F., Hylton, N. M., Middleton, L. P., Krishnamurthy, S., Perkins, G. H., Babiera, G., Edgerton, M. E., Czerniecki, B. J., Arun, B. K., & Hortobagyi, G. N. (2009). Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2008.18.3103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.